However, to reach Phase 3, a new treatment must be proven safe through the first two phases. Before joining a Phase 3 trial, ask the researchers what side effects they observed in the earlier phases.

Roche said on it would advance testing of an antibiotic against a common drug-resistant bacteria that causes serious hospital infections into the third and last phase of testing on humans.

The drug Leqembi (lecanemab-irmb), which began development in 2005 as a collaboration by Eisai (ESAI.Y 0.3%), Biogen (BIIB 1.96%), and BioArctic (BRCT.F-1.29%), received approval from the FDA in ...

Swiss drugmaker Roche said on Monday it would advance testing of an antibiotic against a common drug-resistant bacteria that causes serious hospital infections into the third and last phase of ...